FDA Adverse Event Death Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3053361 · Received April 11, 2013

Report

Report Number
2024168-2013-02202
Event Type
Death
Date Received
April 11, 2013
Date of Event
March 18, 2013
Report Date
March 20, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ME, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4). STENT: XIENCE V 2.5X28, XIENCE V 2.5X15, (2) XIENCE V 2.5X18. THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECT OF DEATH IS LISTED IN THE INSTRUCTIONS FOR USE (IFU) AS A KNOWN ADVERSE EVENT. IN THIS CASE, THE DEATH OCCURRED 4 YRS 5 MONTHS POST-PROCEDURE. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

SUBSEQUENT INFORMATION RECEIVED THAT THE PATIENT EXPIRED FROM A LOWER RESPIRATORY INFECTION LISTED AS BRONCHIAL PNEUMONIA.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2008, TWO XIENCE V STENTS WERE IMPLANTED IN A MID LEFT ANTERIOR DESCENDING ARTERY (LAD), ONE XIENCE V STENT WAS IMPLANTED IN A PROXIMAL LAD, ONE XIENCE V STENT WAS IMPLANTED IN A FIRST OBTUSE MARGINAL ARTERY (OM1), AND ONE XIENCE STENT IN A PROXIMAL LEFT CIRCUMFLEX ARTERY (LCX). APPROXIMATELY, 4 YRS 5 MONTHS LATER, ON (B)(6) 2013, THE PATIENT EXPIRED. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155847 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 8050841

Patients

Seq Age Sex Outcome Treatment
1 82 YR Death CONCOMITANT MEDICAL DEVICES